Lamb, Harriet M.; Goa, Karen L. - In: Disease Management and Health Outcomes 6 (1999) 2, pp. 93-108
toxicity, is sometimes used in this patient group. Inhaled tobramycin, colistin (or colistimethate) and beta-lactam agents … be compared in clinical trials. Recently, tobramycin solution for inhalation (TOBI(R)) has been developed in an attempt …. aeruginosa infection, 3 courses of a 28-day on/28-day off regimen of inhaled tobramycin (TOBI(R)) significantly improved lung …